2 Biotech Stocks Set to Rebound in 2026
Looking to beat the market over the next five years? Here's one strategy to adopt: Invest in stocks that have not performed well recently but boast attractive prospects.
Two intriguing corporations to consider now are Viking Therapeutics (NASDAQ: VKTX) and BioNTech (NASDAQ: BNTX). These biotech companies are somewhat risky, but after terrible performances in 2025, both could rebound this year and deliver strong returns through 2031. Allow me to explain.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Aktie
25,29 €
-0,20 %
Die Viking Therapeutics Inc Aktie ist etwas beliebter: Mehr Buy- (4) als Sell-Einschätzungen (0).
Das niedrigere Kursziel von 25 € im Vergleich zum aktuellen Kurs von 25.29 € für Viking Therapeutics Inc führt zu einem negativen Potenzial von -1.15%.
